Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/285
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
HYCAMTIN (Capsule)
|
| dailymed-instance:activeIng... | |
| dailymed-instance:boxedWarn... |
WARNING: Bone Marrow Suppression: HYCAMTIN should be administered only to patients with baseline neutrophil counts of���1,500 cells/mmand a platelet count���100,000 cells/mm. In order to assess the occurrence of bone marrow suppression, blood cell counts should be monitored.
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:genericMe... |
topotecan hydrochloride
|
| dailymed-instance:fullName |
HYCAMTIN (Capsule)
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
HYCAMTIN
|